Many studies have examined methicillin-resistant Staphylococcus aureus (MRSA) control measures, but few have been planned prospective single intervention studies in the endemic setting. Researchers from the Victorian Infectious Diseases Service of Royal Melbourne Hospital and the Department of Medicine at the University of Melbourne, both in Melbourne, Australia, investigated whether active surveillance and contact precautions (CP) reduced MRSA transmission. In a presentation at the International Conference on Prevention & Infection Control (ICPIC) held in Geneva, Switzerland June 29-July 2, 2011, Marshall, et al. report on their study in which they collected and analyzed data to avoid confounding (of MRSA acquisition with length of stay) and serial dependence due to colonization pressure (CoPr) in accordance with ORION guidelines.
This was an interrupted time series in a tertiary ICU. Standard precautions only were used for control patients regardless of MRSA status. In the intervention period, rapid PCR was used to detect MRSA colonized patients, who were then cared for in CP. The researchers used a generalized estimating equation (GEE) with each patient-day being the unit of interest. The predictor variables were both time-dependent (antibiotic usage, hand hygiene and infection control precaution compliance and CoPr) and time-invariant covariates (co-morbidities, sex and age) and intra-individual risk correlation was adjusted for using the GEE framework.
The primary outcome measure was the effect of the intervention on MRSA acquisition, adjusting for CoPr and individual and ward covariates. The relative risk of MRSA acquisition was 0.40 (95%CI 0.24-0.65). Secondary measures include the effect of colonized patients in the ward (RR 4.38; 95% CI 1.00-19.21)Â and the phase-colonized patient interaction, with a reduced risk from colonized patients in the intervention phase to 0.41 (95% CI 0.14-1.18) compared with the control phase.
Marshall, et al. demonstrated a clinically significant effect of isolation on MRSA transmission. The researchers say their planned single intervention study is unique because of near-complete observations due to short intervals between swabs and full documentation of CoPr and time-varying risk factors.
Reference: Marshall C, McBryde E and Richards M. Do rapid detection and isolation of colonized patients reduce MRSA spread in the intensive care unit? Oral presentation at the International Conference on Prevention & Infection Control (ICPIC). BMC Proceedings 2011, 5(Suppl 6):O88doi:10.1186/1753-6561-5-S6-O88
Â
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.